SHELL ASSET MANAGEMENT CO - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 265 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 2.04 and the average weighting 0.2%.

Quarter-by-quarter ownership
SHELL ASSET MANAGEMENT CO ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2020$366,000
+4.3%
3,6810.0%0.01%0.0%
Q3 2020$351,000
-14.8%
3,6810.0%0.01%
-20.0%
Q2 2020$412,000
+76.1%
3,681
+14.5%
0.01%
+42.9%
Q1 2020$234,000
-31.4%
3,215
-1.5%
0.01%0.0%
Q4 2019$341,000
+1.2%
3,265
-3.6%
0.01%
-12.5%
Q3 2019$337,000
-13.6%
3,388
-0.8%
0.01%
-11.1%
Q2 2019$390,000
-11.2%
3,417
-2.2%
0.01%
-10.0%
Q1 2019$439,000
-7.4%
3,4950.0%0.01%
-16.7%
Q4 2018$474,000
-54.5%
3,495
-7.9%
0.01%
-42.9%
Q3 2018$1,042,000
+107.2%
3,795
-23.1%
0.02%
+110.0%
Q3 2016$503,0004,9320.01%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q1 2020
NameSharesValueWeighting ↓
KNOTT DAVID M 1,199,766$130,078,630,00035.65%
CARDINAL CAPITAL MANAGEMENT LLC /CT 852,053$92,380,0005.34%
OBERWEIS ASSET MANAGEMENT INC/ 101,127$10,964,0003.08%
Timpani Capital Management LLC 68,160$7,390,0003.00%
ASHFORD CAPITAL MANAGEMENT INC 103,420$11,213,0002.64%
First Light Asset Management, LLC 56,818$6,160,0002.58%
Conestoga Capital Advisors, LLC 286,162$31,026,0002.51%
OAK RIDGE INVESTMENTS LLC 955,599$103,606,0002.48%
RK Capital 127,983$13,876,0002.42%
Nichols Asset Management LLC 93,170$10,101,0002.20%
View complete list of LIGAND PHARMACEUTICALS INC shareholders